Literature DB >> 1520657

Botulinum A toxin for (expressionistic) ptosis overcorrection after frontalis sling.

G E Borodic1.   

Abstract

Botulinum A toxin was injected into the frontalis muscle in two patients with complete third nerve palsies to limit intermittent upper lid retraction after a frontalis sling procedure. This form of lid retraction is noted during periods of active facial movement with occipitofrontalis muscle contraction. Although upper lid position may be symmetric when the facial muscles are adynamic, the upper lid may retract during periods of active facial expression. This type of lid retraction was corrected using Botulinum A toxin injections into the frontalis muscles, without affecting the lid position when the facial muscles are adynamic. Both improvement in appearance and intermittent exposure were noted in both cases. Additionally, a blunting of the transverse forehead creases occurred over a defined area after this injection, representing a clinical example of a denervation field produced by a point injection of botulinum toxin.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1520657     DOI: 10.1097/00002341-199206000-00010

Source DB:  PubMed          Journal:  Ophthalmic Plast Reconstr Surg        ISSN: 0740-9303            Impact factor:   1.746


  3 in total

Review 1.  New concepts in botulinum toxin therapy.

Authors:  G E Borodic; L B Pearce
Journal:  Drug Saf       Date:  1994-09       Impact factor: 5.606

2.  Association Between Secondary Botulinum Toxin A Treatment Failure in Cosmetic Indication and Anti-Complexing Protein Antibody Production.

Authors:  Rungsima Wanitphakdeedecha; Watsachon Kantaviro; Panittra Suphatsathienkul; Ploypailin Tantrapornpong; Chadakan Yan; Chalermkwan Apinumtham; Yuttana Srinoulprasert
Journal:  Dermatol Ther (Heidelb)       Date:  2020-05-22

3.  Duration of Clinical Efficacy of OnabotulinumtoxinA in Crow's Feet Lines: Results from Two Multicenter, Randomized, Controlled Trials.

Authors:  Leslie Baumann; Steven Dayan; Simon Connolly; Nancy Silverberg; Xiaofang Lei; Adrienne Drinkwater; Conor J Gallagher
Journal:  Dermatol Surg       Date:  2016-05       Impact factor: 3.398

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.